QYD
- Product code
- QYD
- Device name
- Adalimumab Assay
- Device class
- Class 2
- 21 CFR
- 21 CFR 862.3115
- Medical specialty
- Clinical Toxicology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 0 (direct download)
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
An in vitro diagnostic device intended for the measurement of adalimumab, an anti-tumor necrosis factor alpha monoclonal antibody
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| DEN220023 | 2023-09-29 | Procisedx, Inc. | Procise ADL | — |
Official FDA classification page: QYD
Classification and pathway per current FDA publications. Data from openFDA (CC0).